Just before the end of 2025, an oral version of a GLP-1 drug specifically used for weight management moved much closer to ...

Complete Pricing Comparison Shows FDA-Approved Wegovy Access From $149 Oral to Ro's $199 Injectable Through Telehealth as 1 in 8 Americans Now Use GLP-1 MedicationsNEW YORK, Dec. 30, 2025 (GLOBE ...

The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The Wegovy pill is FDA-approved to reduce excess body weight and maintain weight reduction long-term in adults who have ...

Novo Nordisk plans to sell its newly approved obesity pill directly to patients at a lower price than a competing medicine ...

The FDA has approved a pill form of the popular GLP-1 weight-loss medication Wegovy. Novo Nordisk says it is as effective as ...

The Food and Drug Administration has approved Novo Nordisk’s once-daily Wegovy pill, the first oral GLP-1 medicine for ...

Stocks Refusing to take a Holiday. Novo Nordisk A/S (NYSE:NVO) is one of the last week’s best performers. Novo Nordisk grew ...

The first pills are expected to hit the market next month and attract people who don’t want to give themselves shots.

Wegovy's new pill has been approved in the US, offering a needle-free option with a lower starting price than injections.

Novo Nordisk’s oral Wegovy gets FDA approval, but rising costs and competition threaten profits. Learn why analysts rate NVO ...